Transcutaneous Auricular Vagus Enhanced Recovery in the NeuroICU
RecruitingNCT07219108Phase: NAStarted 2025-09-24
Summary
This study will demonstrate the impact of taVNS on reducing adverse events in NeuroICU patients, determine if taVNS reduces length of stay, and quantify the economic benefits of taVNS implementation i
Eligibility
Sex
ALL
Min Age
18 Years
Max Age
None
Locations
Washington University School of MedicineSt Louis, Missouri, United States
View full study details on ClinicalTrials.gov
clinicaltrials.gov/study/NCT07219108